AstraZeneca PLC (NYSE:AZN)
| 44.68 Delayed Data As of Mar 31 |  +0.02 / +0.04%Today’s Change | 36.15 Today|||52-Week Range 51.55 | -10.39% Year-to-Date |
Latest AZN News | Press Releases
| Better Coronavirus Stock: Inovio Pharmaceuticals or GlaxoSmithKline? Mar 20 / MotleyFool.com - Paid Partner Content | AbbVie Strikes Deal With the FTC to Move Its Allergan Acquisition Forward Mar 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.66 |
| Today’s open | 44.02 |
| Day’s range | 43.86 - 45.11 |
| Volume | 1,400 |
| Average volume (3 months) | 3,790,631 |
| Market cap | $111.5B |
Data as of 4:59pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -39.32% |
| Earnings growth (this year) | +15.38% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | +16.27% |
| P/E ratio | 86.7 |
| Price/Sales | 5.06 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.97 | -2.17% |
| ABBVAbbVie | +0.08 | +0.11% |
| BMYBristol-Myers Squibb | -0.64 | -1.15% |
| NVONovo Nordisk | -0.01 | -0.02% |
Data as of 6:07pm ET, 03/31/2020
Financials
| Next reporting date | April 29, 2020 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $25.6B |
| Annual profit (last year) | $1.3B |
| Net profit margin | 5.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
